Get notified of page updates

Featured Research Search Results

PRINTER FRIENDLY PAGE

Search

Virtual
Virtual
PRINTER FRIENDLY PAGE
32 Results Found

Featured research search results for

Ovarian
VIRTUAL

IGNITE-TX - Identifying Individuals for Genetic Testing for Familial Cancer

Clinicaltrials.gov identifier:
NCT07318363

Prevention
People with a genetic mutation in BRCA1, BRCA2 or Lynch syndrome who have relatives who have not been tested

Phase 3

VIRTUAL

Virtual Exercise Classes for Adult Cancer Survivors (SURGE)

Clinicaltrials.gov identifier:
NCT07290309

Quality of Life
Exercise study for people diagnosed within the past 5 years

Treating Advanced MSI-High or dMMR Cancers Using the Targeted Therapy MOMA-341 Given Alone or In Combination with Standard Therapies

Clinicaltrials.gov identifier:
NCT06974110

Treatment
Treatment study for people with advanced or metastatic cancers

Phase 1

REKINDLE: Your Ability to Cope With a Life-Changing Medical Diagnosis

Clinicaltrials.gov identifier:
NCT07002034

Quality of Life
Study for those experiencing mental health struggles due to a diagnosis of cancer or other medical illness

Phase 2

A New Drug, DT2216, Combined With Paclitaxel for Recurrent Platinum-Resistant Ovarian Cancer

Clinicaltrials.gov identifier:
NCT06964009

Treatment
Treatment study for people with recurrent platinum-resistant ovarian cancer

Phase 1

Multi-Cancer Detection Blood Tests in Adults Without Cancer: Vanguard Study

Clinicaltrials.gov identifier:
NCT06995898

Prevention
A study testing two multi-cancer detection blood tests in people who do not have cancer

Psilocybin Therapy in Advanced Cancer

Clinicaltrials.gov identifier:
NCT05398484

Quality of Life
Study for people with advanced cancer

Phase 2

Comparing Treatment with Sacituzumab Govitecan and Bevacizumab to Chemotherapy and Bevacizumab for Recurrent Ovarian Cancer After PARP Inhibitor Maintenance Therapy

Clinicaltrials.gov identifier:
NCT07504588

Treatment
Study for platinum-sensitive ovarian cancer that has progressed after PARP inhibitor

Phase 2

VIRTUAL

A 5-minute Patient and Caregiver survey to share experiences with immunotherapy and any short-term or long-term side effects

Surveys, Registries, Interviews
Survey on immunotherapy to share experiences, including side effects and whether they were resolved or not

Testing the Drug CX-5461 for Treating Metastatic Solid Tumors

Clinicaltrials.gov identifier:
NCT06606990

Treatment
Phase 1 study for treatment of advanced solid tumors

Phase 1

Testing a Targeted Therapy ETX-19477 to Treat Advanced Solid Tumors in People with a BRCA2 Mutation (ERADIC8)

Clinicaltrials.gov identifier:
NCT06395519

Treatment
Treatment study for people with advanced breast, colorectal, endometrial, ovarian or pancreatic cancer

Phase 1/2

Using a Blood Test to Detect Early Cancer Recurrence After Treatment (ORACLE)

Clinicaltrials.gov identifier:
NCT05059444

Treatment
Post-treatment study to monitor for recurrence

VIRTUAL

An Early Detection and Prevention Study for People with an Increased Risk of Cancer (InAdvance)

Clinicaltrials.gov identifier:
NCT05463796

Prevention
Study for people at risk of cancer, including previvors, survivors and family members

VIRTUAL

The EASE Study: Helping People with Advanced Cancer Cope with Fear of Cancer Progression

Clinicaltrials.gov identifier:
NCT07636200

Quality of Life
Quality of life study for people with advanced cancer experiencing anxiety

A Study of Fallopian Tube Removal with Delayed Ovary Removal to Lower Ovarian Cancer Risk (TUBA-WISP-II)

Clinicaltrials.gov identifier:
NCT04294927

Prevention
Prevention study for women at high risk for ovarian cancer

Treating Advanced Breast or Other Solid Cancers Using a Combination of a New Targeted Therapy, ZEN003694, With The Targeted Therapy Abemaciclib (Verzenio)

Clinicaltrials.gov identifier:
NCT05372640

Treatment
Phase 1 treatment study for advanced breast cancer and other solid tumors

Phase 1

Study of a New Investigational Inhibitor to Treat People with Advanced Solid Tumors

Clinicaltrials.gov identifier:
NCT05932862

Treatment
Treatment study for people with advanced solid tumors

Phase 1